The prognostic value of tumour-infiltrating lymphocytes in pancreatic cancer: a systematic review and meta-analysis

Breast Cancer

Prognostic value of tumour-infiltrating lymphocytes in small HER2-positive breast cancer

Eur J Cancer.

Criscitiello C, Bagnardi V, Pruneri G, Vingiani A, Esposito A, Rotmensz N, Curigliano G

doi: 10.1016/j.ejca.2017.10.011.

Gynecologic Cancer

Efficacy of cancer vaccines in selected gynaecological breast and ovarian cancers: A 20-year systematic review and meta-analysis

Eur J Cancer.

Dafni U, Martín-Lluesma S, Balint K, Tsourti Z, Vervita K, Chenal J, Coukos G, Zaman K, Sarivalasis A, Kandalaft LE

doi: 10.1016/j.ejca.2020.10.014.

Breast Cancer

Integration of tumour infiltrating lymphocytes, programmed cell-death ligand-1, CD8 and FOXP3 in prognostic models for triple-negative breast cancer: Analysis of 244 stage I-III patients treated with standard therapy

Eur J Cancer.

Dieci MV, Tsvetkova V, Griguolo G, Miglietta F, Tasca G, Giorgi CA, Cumerlato E, Massa D, Lo Mele M, Orvieto E, Guarneri V, Conte P

doi: 10.1016/j.ejca.2020.05.014.

Breast Cancer

Predictive and prognostic value of stromal tumour-infiltrating lymphocytes before and after neoadjuvant therapy in triple negative and HER2-positive breast cancer

Eur J Cancer.

Ochi T, Bianchini G, Ando M, Nozaki F, Kobayashi D, Criscitiello C, Curigliano G, Iwamoto T, Niikura N, Takei H, Yoshida A, Takei J, Suzuki K, Yamauchi H, Hayashi N

doi: 10.1016/j.ejca.2019.05.014.

Skin Cancer

Risk of treatment-related mortality in cancer patients treated with ipilimumab: A systematic review and meta-analysis

Eur J Cancer.

Zhang S, Liang F, Li W, Wang Q

doi: 10.1016/j.ejca.2017.06.021.

Gastrointestinal Cancer

Should platinum-based chemotherapy be preferred for germline BReast CAncer genes (BRCA) 1 and 2-mutated pancreatic ductal adenocarcinoma (PDAC) patients? A systematic review and meta-analysis

Cancer Treat Rev.

Rebelatto TF, Falavigna M, Pozzari M, Spada F, Cella CA, Laffi A, Pellicori S, Fazio N

doi: 10.1016/j.ctrv.2019.101895.

RECOMMENDED

Lung, Respiratory and Thoracic Cancer

Addition of radiotherapy to the primary tumour in oligometastatic NSCLC: A systematic review and meta-analysis

Lung Cancer.

Petrelli F, Ghidini A, Cabiddu M, Tomasello G, De Stefani A, Bruschieri L, Vitali E, Ghilardi M, Borgonovo K, Barni S, Trevisan F

doi: 10.1016/j.lungcan.

Breast Cancer

Phosphoinositide 3-kinase inhibitors in advanced breast cancer: A systematic review and meta-analysis

Eur J Cancer.

Raphael J, Desautels D, Pritchard KI, Petkova E, Shah PS

doi: 10.1016/j.ejca.2017.12.010.

Lung, Respiratory and Thoracic Cancer

Efficacy and safety of ALK inhibitors in ALK-rearranged non-small cell lung cancer: A systematic review and meta-analysis

Lung Cancer.

Breadner D, Blanchette P, Shanmuganathan S, Boldt RG, Raphael J

doi: 10.1016/j.lungcan.

Related content

Prognostic value of tumour-infiltrating lymphocytes in small HER2-positive breast cancer

Efficacy of cancer vaccines in selected gynaecological breast and ovarian cancers: A 20-year systematic review and meta-analysis

Integration of tumour infiltrating lymphocytes, programmed cell-death ligand-1, CD8 and FOXP3 in prognostic models for triple-negative breast cancer: Analysis of 244 stage I-III patients treated with standard therapy

Predictive and prognostic value of stromal tumour-infiltrating lymphocytes before and after neoadjuvant therapy in triple negative and HER2-positive breast cancer

Risk of treatment-related mortality in cancer patients treated with ipilimumab: A systematic review and meta-analysis

Should platinum-based chemotherapy be preferred for germline BReast CAncer genes (BRCA) 1 and 2-mutated pancreatic ductal adenocarcinoma (PDAC) patients? A systematic review and meta-analysis

Addition of radiotherapy to the primary tumour in oligometastatic NSCLC: A systematic review and meta-analysis

Phosphoinositide 3-kinase inhibitors in advanced breast cancer: A systematic review and meta-analysis

Efficacy and safety of ALK inhibitors in ALK-rearranged non-small cell lung cancer: A systematic review and meta-analysis